Literature DB >> 11900615

A putative sigma1 receptor antagonist NE-100 attenuates the discriminative stimulus effects of ketamine in rats.

Minoru Narita1, Kazumi Yoshizawa, Kazue Aoki, Misa Takagi, Mayumi Miyatake, Tsutomu Suzuki.   

Abstract

Ketamine, one of the dissociative anaesthetic agents, has been shown to produce psychotomimetic effects. It has been well documented that activation of sigma receptors is responsible for the pathogenesis of some psychiatric disorders. In the present study, the effects of NE-100, a putative sigma(1) receptor antagonist, was investigated in rats trained to discriminate between ketamine (5 mg/kg, i.p.) from saline under a fixed-ratio 10 food-reinforced procedure. Here we report for the first time that NE-100 (1 mg/kg) produced a shift to the right in the dose-response curve for ketamine's discriminative stimulus effects. These results suggest that the sigma(1) receptor is, at least in part, involved in the discriminative stimulus effects of ketamine.

Entities:  

Year:  2001        PMID: 11900615     DOI: 10.1080/13556210020077091

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  13 in total

1.  Effects of the selective sigma receptor ligand, 1-(2-phenethyl)piperidine oxalate (AC927), on the behavioral and toxic effects of cocaine.

Authors:  Rae R Matsumoto; Su-Min Li; Jonathan L Katz; William E Fantegrossi; Andrew Coop
Journal:  Drug Alcohol Depend       Date:  2011-03-21       Impact factor: 4.492

2.  Ketamine-xylazine anesthesia causes hyperopic refractive shift in mice.

Authors:  Tatiana V Tkatchenko; Andrei V Tkatchenko
Journal:  J Neurosci Methods       Date:  2010-09-08       Impact factor: 2.390

3.  Effects of anesthetic regimes on inflammatory responses in a rat model of acute lung injury.

Authors:  Spyridon Fortis; Peter M Spieth; Wei-Yang Lu; Matteo Parotto; Jack J Haitsma; Arthur S Slutsky; Nanshan Zhong; C David Mazer; Haibo Zhang
Journal:  Intensive Care Med       Date:  2012-06-19       Impact factor: 17.440

4.  Sigma receptor activation inhibits voltage-gated sodium channels in rat intracardiac ganglion neurons.

Authors:  Hongling Zhang; Christopher Katnik; Javier Cuevas
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2009-11-15

5.  Neuroprotective Effects of σ2R/TMEM97 Receptor Modulators in the Neuronal Model of Huntington's Disease.

Authors:  Jing Jin; Nicolas Arbez; James J Sahn; Yan Lu; Kathryn T Linkens; Timothy R Hodges; Anthony Tang; Robyn Wiseman; Stephen F Martin; Christopher A Ross
Journal:  ACS Chem Neurosci       Date:  2022-09-15       Impact factor: 5.780

Review 6.  Sigma Receptors and Substance Use Disorders.

Authors:  Valentina Sabino; Callum Hicks; Pietro Cottone
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 3.650

Review 7.  Regulation of opioid receptor signalling: implications for the development of analgesic tolerance.

Authors:  Karim Nagi; Graciela Piñeyro
Journal:  Mol Brain       Date:  2011-06-13       Impact factor: 4.041

8.  Gene expression changes in GABA(A) receptors and cognition following chronic ketamine administration in mice.

Authors:  Sijie Tan; John A Rudd; David T Yew
Journal:  PLoS One       Date:  2011-06-21       Impact factor: 3.240

9.  Preventive Treatment with Ketamine Attenuates the Ischaemia-Reperfusion Response in a Chronic Postischaemia Pain Model.

Authors:  Suryamin Liman; Chi Wai Cheung; Kar Lok Wong; Wai Tai; Qiu Qiu; Kwok Fu Ng; Siu Wai Choi; Michael Irwin
Journal:  Oxid Med Cell Longev       Date:  2015-06-16       Impact factor: 6.543

10.  Ketamine induces a robust whole-brain connectivity pattern that can be differentially modulated by drugs of different mechanism and clinical profile.

Authors:  R Joules; O M Doyle; A J Schwarz; O G O'Daly; M Brammer; S C Williams; M A Mehta
Journal:  Psychopharmacology (Berl)       Date:  2015-05-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.